196 related articles for article (PubMed ID: 30027430)
1. A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model.
Kim JW; Kane JR; Panek WK; Young JS; Rashidi A; Yu D; Kanojia D; Hasan T; Miska J; Gómez-Lim MA; Ulasov IV; Balyasnikova IV; Ahmed AU; Wainwright DA; Lesniak MS
Neurotherapeutics; 2018 Oct; 15(4):1127-1138. PubMed ID: 30027430
[TBL] [Abstract][Full Text] [Related]
2. Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.
Tenbusch M; Nchinda G; Storcksdieck genannt Bonsmann M; Temchura V; Überla K
Int Immunol; 2013 Apr; 25(4):247-58. PubMed ID: 23184617
[TBL] [Abstract][Full Text] [Related]
3. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
[TBL] [Abstract][Full Text] [Related]
5. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor.
Broder H; Anderson A; Odesa SK; Kremen TJ; Liau LM
Neurosurg Focus; 2000 Dec; 9(6):e6. PubMed ID: 16817689
[TBL] [Abstract][Full Text] [Related]
6. MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor.
Broder H; Anderson A; Kremen TJ; Odesa SK; Liau LM
J Neurooncol; 2003; 64(1-2):21-30. PubMed ID: 12952283
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination.
Wan Y; Bramson J; Carter R; Graham F; Gauldie J
Hum Gene Ther; 1997 Jul; 8(11):1355-63. PubMed ID: 9295130
[TBL] [Abstract][Full Text] [Related]
8. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
[TBL] [Abstract][Full Text] [Related]
9. Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.
Gong HX; He L; Li XP; Wang YD; Li Y; Huang JJ; Wang Z; Xie D; Kung HF; Peng Y
Oncol Rep; 2012 Apr; 27(4):1163-9. PubMed ID: 22210010
[TBL] [Abstract][Full Text] [Related]
10. High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN.
Korokhov N; de Gruijl TD; Aldrich WA; Triozzi PL; Banerjee PT; Gillies SD; Curiel TJ; Douglas JT; Scheper RJ; Curiel DT
Cancer Biol Ther; 2005 Mar; 4(3):289-94. PubMed ID: 15753654
[TBL] [Abstract][Full Text] [Related]
11. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
[TBL] [Abstract][Full Text] [Related]
12. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J
Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893
[TBL] [Abstract][Full Text] [Related]
13. Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.
Schloss J; Ali R; Babad J; Guerrero-Ros I; Pongsachai J; He LZ; Keler T; DiLorenzo TP
Immunohorizons; 2019 Jun; 3(6):236-253. PubMed ID: 31356169
[TBL] [Abstract][Full Text] [Related]
14. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.
Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H
Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848
[TBL] [Abstract][Full Text] [Related]
16. Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.
Dey M; Chang AL; Miska J; Wainwright DA; Ahmed AU; Balyasnikova IV; Pytel P; Han Y; Tobias A; Zhang L; Qiao J; Lesniak MS
J Immunol; 2015 Jul; 195(1):367-76. PubMed ID: 26026061
[TBL] [Abstract][Full Text] [Related]
17. Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver.
Volckmar J; Gereke M; Ebensen T; Riese P; Philipsen L; Lienenklaus S; Wohlleber D; Klopfleisch R; Stegemann-Koniszewski S; Müller AJ; Gruber AD; Knolle P; Guzman CA; Bruder D
Sci Rep; 2017 Mar; 7():43985. PubMed ID: 28266658
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.
Feng S; Han S; Pan D; Liu M; Feng X; Dong T; Li W; Wei X
Tumour Biol; 2014 May; 35(5):4411-7. PubMed ID: 24408016
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.
Tillman BW; Hayes TL; DeGruijl TD; Douglas JT; Curiel DT
Cancer Res; 2000 Oct; 60(19):5456-63. PubMed ID: 11034088
[TBL] [Abstract][Full Text] [Related]
20. Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells.
Xu M; Yao Y; Hua W; Wu Z; Zhong P; Mao Y; Zhou L; Luo F; Chu Y
J Neurooncol; 2014 Feb; 116(3):497-504. PubMed ID: 24398615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
